Show simple item record

dc.contributor.authorDeen, Jen
dc.contributor.authorLopez, ALen
dc.contributor.authorKanungo, Sen
dc.contributor.authorWang, XYen
dc.contributor.authorAnh, DDen
dc.contributor.authorTapia, Men
dc.contributor.authorGrais, RFen
dc.date.accessioned2018-02-06T16:30:16Z
dc.date.available2018-02-06T16:30:16Z
dc.date.issued2017-11-14
dc.date.submitted2018-02-01
dc.identifier.citationImproving rotavirus vaccine coverage: Can newer-generation and locally produced vaccines help? 2017:1-5 Hum Vaccin Immunotheren
dc.identifier.issn2164-554X
dc.identifier.pmid29135339
dc.identifier.doi10.1080/21645515.2017.1403705
dc.identifier.urihttp://hdl.handle.net/10144/619068
dc.description.abstractThere are two internationally available WHO-prequalified oral rotavirus vaccines (Rotarix and RotaTeq), two rotavirus vaccines licensed in India (Rotavac and Rotasiil), one in China (Lanzhou lamb rotavirus vaccine) and one in Vietnam (Rotavin-M1), and several candidates in development. Rotavirus vaccination has been rolled out in Latin American countries and is beginning to be deployed in sub-Saharan African countries but middle- and low-income Asian countries have lagged behind in rotavirus vaccine introduction. We provide a mini-review of the leading newer-generation rotavirus vaccines and compare them with Rotarix and RotaTeq. We discuss how the development and future availability of newer-generation rotavirus vaccines that address the programmatic needs of poorer countries may help scale-up rotavirus vaccination where it is needed.
dc.language.isoenen
dc.publisherTaylor & Francisen
dc.rightsArchived with thanks to Human Vaccines & Immunotherapeuticsen
dc.titleImproving rotavirus vaccine coverage: Can newer-generation and locally produced vaccines help?en
dc.identifier.journalHuman Vaccines & Immunotherapeuticsen
refterms.dateFOA2019-03-04T13:44:55Z
html.description.abstractThere are two internationally available WHO-prequalified oral rotavirus vaccines (Rotarix and RotaTeq), two rotavirus vaccines licensed in India (Rotavac and Rotasiil), one in China (Lanzhou lamb rotavirus vaccine) and one in Vietnam (Rotavin-M1), and several candidates in development. Rotavirus vaccination has been rolled out in Latin American countries and is beginning to be deployed in sub-Saharan African countries but middle- and low-income Asian countries have lagged behind in rotavirus vaccine introduction. We provide a mini-review of the leading newer-generation rotavirus vaccines and compare them with Rotarix and RotaTeq. We discuss how the development and future availability of newer-generation rotavirus vaccines that address the programmatic needs of poorer countries may help scale-up rotavirus vaccination where it is needed.


Files in this item

Thumbnail
Name:
Deen et al - 2017 - Improving ...
Size:
878.8Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record